amiodarone has been researched along with aspirin in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.86) | 18.7374 |
1990's | 7 (20.00) | 18.2507 |
2000's | 11 (31.43) | 29.6817 |
2010's | 15 (42.86) | 24.3611 |
2020's | 1 (2.86) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Bryant, DH | 1 |
Fouchard, J; Guérin, F; Le, F; Py, A | 1 |
D'Arcy, PF | 1 |
Preobrazhenskiĭ, DV | 1 |
Disch, DL; Greenberg, ML; Malenka, DJ | 1 |
Piazza, V; Rulli, F | 1 |
Kausar, SA | 1 |
Carrión Valero, F; Marín Pardo, J | 1 |
Cieśliński, A; Grajek, S; Grygier, M; Mularek-Kubzdela, T; Seniuk, W | 1 |
Corley, SD; DiMarco, JP; Flaker, G; Greene, HL; Mitrani, G; Nemeth, M; Rosenfeld, LE; Safford, RE; Waldo, AL | 1 |
Chiribiri, A; Di Bella, G; Marte, F; Patanè, S | 1 |
Cervera, AM; Llorach, I; Miralles, R; Nogueras, C; Roig, A | 1 |
Kubo, K | 1 |
Alonso, A; Hermida, J; Montes, R; Nantes, O; Zozaya, JM | 1 |
Guo, X; Li, L; Tang, B; Xu, G; Zhang, Y; Zhou, X | 1 |
Aguilar, C | 1 |
Camargo, HP; Girotto, E; Guidoni, CM; Obreli-Neto, PR; Pereira, LR | 1 |
Beilmann, M; Christoffersson, J; Coffee, M; Kempf, H; Mandenius, CF; Meier, F; Schwanke, K; Zweigerdt, R | 1 |
Fujibuchi, W; Kobayashi, K; Panina, Y; Sone, H; Yamane, J | 1 |
8 review(s) available for amiodarone and aspirin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced pulmonary disease.
Topics: Adrenergic beta-Antagonists; Adverse Drug Reaction Reporting Systems; Aerosols; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Aspirin; Bronchial Spasm; Contrast Media; Cough; Drug-Related Side Effects and Adverse Reactions; Humans; Lung Diseases; Nitrofurantoin | 1992 |
[Isolated atrial fibrillation. The risk of embolism and its prevention].
Topics: 4-Hydroxycoumarins; Adult; Aged; Aged, 80 and over; Amiodarone; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Indenes; Intracranial Embolism and Thrombosis; Male; Middle Aged; Recurrence; Risk Factors; Vitamin K; Warfarin | 1992 |
[Secondary prevention after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Captopril; Humans; Myocardial Infarction | 1993 |
Therapeutic strategies for atrial fibrillation. The value of decision analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Decision Support Techniques; Electric Countershock; Humans; Markov Chains; Quinidine; Randomized Controlled Trials as Topic; Warfarin | 1996 |
[Pulmonary toxicity caused by drugs].
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents, Urinary; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Antineoplastic Agents; Aspirin; Bleomycin; Drug-Related Side Effects and Adverse Reactions; Humans; Lung; Lung Diseases; Nitrofurantoin; Oxygen Inhalation Therapy; Platelet Aggregation Inhibitors; Pulmonary Fibrosis; Radiography, Thoracic; Respiratory Insufficiency; Vasodilator Agents | 1999 |
[Drug-induced pulmonary edema].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Gefitinib; Glucocorticoids; Humans; Immunosuppressive Agents; Norepinephrine; Pulmonary Edema; Quinazolines; Respiration, Artificial; Risk Factors | 2007 |
Antithrombotic therapy in a patient with mild haemophilia A and atrial fibrillation: case report and brief review of the literature.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Disease Management; Dronedarone; Fibrinolytic Agents; Hemophilia A; Hemorrhage; Humans; Male; Thrombophilia | 2015 |
1 trial(s) available for amiodarone and aspirin
Article | Year |
---|---|
Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Life Tables; Male; Middle Aged; Risk; Stroke; Thromboembolism; Warfarin | 2005 |
26 other study(ies) available for amiodarone and aspirin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden.
Topics: Amiodarone; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Anticoagulants; Arteriosclerosis; Aspirin; Cardiology; Coronary Disease; Enoxaparin; Eptifibatide; Europe; Humans; Peptides; Platelet Aggregation Inhibitors; Societies, Medical; Thrombolytic Therapy | 1997 |
Heart failure: a diagnostic and therapeutic dilemma in elderly patients.
Topics: Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Myocardial Infarction; Warfarin | 1999 |
Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study.
Topics: Amiodarone; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Diltiazem; Electrocardiography; Female; Follow-Up Studies; Heart Arrest; Heart Block; Humans; Male; Middle Aged; Nitrates; Nitroglycerin; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Spasm; Time Factors; Vasodilator Agents; Ventricular Fibrillation | 2002 |
Conduction disturbances and paroxysmal atrial fibrillation during acute inferior myocardial infarction.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Atropine; Cortisone; Heart Conduction System; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Nitrates; Platelet Aggregation Inhibitors; Potassium | 2008 |
Polypharmacy as part of comprehensive geriatric assessment: disclosure of false diagnosis of atrial fibrillation by drug revision.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Artifacts; Aspirin; Atrial Fibrillation; Diagnostic Errors; Electrocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Geriatric Assessment; Humans; Medication Errors; Polypharmacy; Tremor | 2007 |
The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Case-Control Studies; Cytochrome P-450 CYP2C9; Drug Administration Schedule; Female; Gastrointestinal Hemorrhage; Genetic Predisposition to Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; International Normalized Ratio; Male; Mixed Function Oxygenases; Odds Ratio; Polymorphism, Genetic; Risk; Vitamin K Epoxide Reductases | 2008 |
[The clinical analysis of atrial fibrillation of 1 310 in patients in Urumqi of China].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; China; Comorbidity; Diabetes Mellitus; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Humans; Hypertension; Incidence; Inpatients; Male; Morpholines; Retrospective Studies; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Warfarin | 2014 |
Study of warfarin utilization in hospitalized patients: analysis of possible drug interactions.
Topics: Adult; Aged; Amiodarone; Anticoagulants; Aspirin; Brazil; Cross-Sectional Studies; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Hospitalization; Humans; Male; Middle Aged; Tertiary Care Centers; Warfarin | 2016 |
Evaluating the Effect of Drug Compounds on Cardiac Spheroids Using the Cardiac Cell Outgrowth Assay.
Topics: Amiodarone; Aspirin; Biological Assay; Cell Culture Techniques; Doxorubicin; Extracellular Matrix; High-Throughput Screening Assays; Humans; Myocytes, Cardiac; Spheroids, Cellular | 2019 |
Human ES and iPS cells display less drug resistance than differentiated cells, and naïve-state induction further decreases drug resistance.
Topics: Amiodarone; Animals; Aspirin; Atorvastatin; Cell Differentiation; Cell Line; Clotrimazole; Drug Resistance; Drug Resistance, Multiple; Embryonic Stem Cells; Humans; Induced Pluripotent Stem Cells | 2021 |